Both PSP-RS and vPSP phenotypes take a chronicprogressive and ultimately fatal disease course, leading to death after a mean of 6–7 years.Clinical progression appears to be determined by the progressive spreading of 4R-tau pathologywithin the brain. Here, MAPT is linked to supranuclear palsy, progressive, 1.